Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1969 1
1970 1
1977 1
1984 1
1986 1
1987 4
1989 1
1991 1
1992 1
1993 4
1994 4
1995 5
1996 7
1997 4
1998 4
1999 6
2000 4
2001 2
2002 10
2003 4
2004 6
2005 4
2006 6
2007 6
2008 7
2009 6
2010 17
2011 10
2012 13
2013 11
2014 12
2015 12
2016 6
2017 14
2018 11
2019 8
2020 9
2021 11
2022 17
2023 16
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

251 results

Results by year

Filters applied: . Clear all
Page 1
Blood-brain barrier models: Rationale for selection.
Hanafy AS, Dietrich D, Fricker G, Lamprecht A. Hanafy AS, et al. Among authors: fricker g. Adv Drug Deliv Rev. 2021 Sep;176:113859. doi: 10.1016/j.addr.2021.113859. Epub 2021 Jul 9. Adv Drug Deliv Rev. 2021. PMID: 34246710 Review.
Radionuclides in drug development.
Uhl P, Fricker G, Haberkorn U, Mier W. Uhl P, et al. Among authors: fricker g. Drug Discov Today. 2015 Feb;20(2):198-208. doi: 10.1016/j.drudis.2014.09.027. Epub 2014 Oct 7. Drug Discov Today. 2015. PMID: 25304182 Review.
ABC transporters at the blood-brain barrier.
Mahringer A, Fricker G. Mahringer A, et al. Among authors: fricker g. Expert Opin Drug Metab Toxicol. 2016 May;12(5):499-508. doi: 10.1517/17425255.2016.1168804. Epub 2016 Apr 4. Expert Opin Drug Metab Toxicol. 2016. PMID: 26998936 Review.
A prolyl oligopeptidase inhibitor reduces tau pathology in cellular models and in mice with tauopathy.
Eteläinen TS, Silva MC, Uhari-Väänänen JK, De Lorenzo F, Jäntti MH, Cui H, Chavero-Pieres M, Kilpeläinen T, Mechtler C, Svarcbahs R, Seppälä E, Savinainen JR, Puris E, Fricker G, Gynther M, Julku UH, Huttunen HJ, Haggarty SJ, Myöhänen TT. Eteläinen TS, et al. Among authors: fricker g. Sci Transl Med. 2023 Apr 12;15(691):eabq2915. doi: 10.1126/scitranslmed.abq2915. Epub 2023 Apr 12. Sci Transl Med. 2023. PMID: 37043557
Aluminum and ABC transporter activity.
Oezen G, Kraus L, Schentarra EM, Bolten JS, Huwyler J, Fricker G. Oezen G, et al. Among authors: fricker g. Environ Toxicol Pharmacol. 2024 Jun;108:104451. doi: 10.1016/j.etap.2024.104451. Epub 2024 Apr 20. Environ Toxicol Pharmacol. 2024. PMID: 38648870 Free article.
Archaeal lipids in oral delivery of therapeutic peptides.
Jacobsen AC, Jensen SM, Fricker G, Brandl M, Treusch AH. Jacobsen AC, et al. Among authors: fricker g. Eur J Pharm Sci. 2017 Oct 15;108:101-110. doi: 10.1016/j.ejps.2016.12.036. Epub 2017 Jan 17. Eur J Pharm Sci. 2017. PMID: 28108360 Review.
Radioligands for Tropomyosin Receptor Kinase (Trk) Positron Emission Tomography Imaging.
Schirrmacher R, Bailey JJ, Mossine AV, Scott PJH, Kaiser L, Bartenstein P, Lindner S, Kaplan DR, Kostikov A, Fricker G, Mahringer A, Rosa-Neto P, Schirrmacher E, Wängler C, Wängler B, Thiel A, Soucy JP, Bernard-Gauthier V. Schirrmacher R, et al. Among authors: fricker g. Pharmaceuticals (Basel). 2019 Jan 3;12(1):7. doi: 10.3390/ph12010007. Pharmaceuticals (Basel). 2019. PMID: 30609832 Free PMC article. Review.
Current status in the therapy of liver diseases.
Uhl P, Fricker G, Haberkorn U, Mier W. Uhl P, et al. Among authors: fricker g. Int J Mol Sci. 2014 Apr 30;15(5):7500-12. doi: 10.3390/ijms15057500. Int J Mol Sci. 2014. PMID: 24786290 Free PMC article. Review.
251 results